- $28.40m
- $31.76m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.8 | 0.12 | n/a | 4.36 | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Company’s Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Company’s trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.
Directors
- Ronald Erickson CHM (77)
- Phillip Bosua CEO (47)
- William Owens IND (81)
- Jon Pepper IND (70)
- Ichiro Takesako IND (62)
- Last Annual
- September 30th, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- October 8th, 1998
- Public Since
- April 12th, 2006
- No. of Shareholders
- 190
- No. of Employees
- 15
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NYSE MKT- Shares in Issue
- 105,984,282
- Address
- 619 WESTERN AVENUE, SUITE 610, SEATTLE, 98104
- Web
- https://www.knowlabs.co/
- Phone
- +1 2069031351
- Contact
- Peter Conley
- Auditors
- BPM LLP
Upcoming Events for KNW
Q4 2024 Know Labs Inc Earnings Release
Q1 2025 Know Labs Inc Earnings Release
Similar to KNW
Acme United
NYSE MKT
Alpha Pro Tech
NYSE MKT
Catheter Precision
NYSE MKT
Electromed
NYSE MKT
Infusystem Holdings
NYSE MKT
FAQ
What is the Know Labs share price?
As of Today at 21:37 UTC, shares in Know Labs are trading at $0.27. This share price information is delayed by 15 minutes.
How has the Know Labs share price performed this year?
Shares in Know Labs last closed at $0.27 and the price had moved by -49.61% over the past 365 days. In terms of relative price strength the Know Labs share price has underperformed the S&P500 Index by -58.47% over the past year.
What are the analyst and broker recommendations for Know Labs?
The overall consensus recommendation for Know Labs is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Know Labs dividend yield?
Know Labs does not currently pay a dividend.
Does Know Labs pay a dividend?
Know Labs does not currently pay a dividend.
When does Know Labs next pay dividends?
Know Labs does not currently pay a dividend.
How do I buy Know Labs shares?
To buy shares in Know Labs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Know Labs?
As of the previous close price of $0.27, shares in Know Labs had a market capitalisation of $28.40m.
Where are Know Labs shares listed?
Here are the trading details for Know Labs:
- Country of listing: United States
- Exchange: ASQ
- Ticker Symbol: KNW
What kind of share is Know Labs?
Based on an overall assessment of its quality, value and momentum Know Labs is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Know Labs share price forecast for 2024?
The analyst consensus target price for shares in Know Labs is $1.00. That is 273.13% above the last closing price of $0.27.
Analysts covering Know Labs currently have a consensus Earnings Per Share (EPS) forecast of -$0.21 for the next financial year.
Find out moreWhat is the trend in the Know Labs share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Know Labs. Over the past six months, its share price has underperformed the S&P500 Index by -61.42%.
As of the last closing price of $0.27, shares in Know Labs were trading -49.46% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Know Labs PE Ratio?
The Know Labs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.27.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Know Labs?
Know Labs' management team is headed by:
- Ronald Erickson - CHM
- Phillip Bosua - CEO
- William Owens - IND
- Jon Pepper - IND
- Ichiro Takesako - IND